RT Book, Section
A1 Bissonnette, Bruno
A1 Luginbuehl, Igor
A1 Marciniak, Bruno
A1 Dalens, Bernard J.
SR Print(0)
ID 58076196
T1 Miller Fisher Syndrome
T2 Syndromes: Rapid Recognition and Perioperative Implications
YR 2006
FD 2006
PB The McGraw-Hill Companies
PP New York, NY
SN 9780071354554
LK accessanesthesiology.mhmedical.com/content.aspx?aid=58076196
RD 2024/04/25
AB Rare,  acquired  nerve  disease  considered  to  be  a  variant  of  Guillain-Barré  syndrome.  It  is  characterized  by  abnormal  muscle  coordination,  ophthalmoplegia,  and  tendon  areflexia.  As  with  Guillain-Barré  syndrome,  the  symptoms  may  be  preceded  by  a  viral  illness.  Other  clinical  features  include  generalized  muscle  weakness  and  respiratory  failure.  The  prognosis  is  good,  with  recovery  beginning  within  2  to  4  weeks  and  almost  completed  within  6  months.  Residual  neurologic  deficits  may  occur,  and  relapses  occur  in  less  than  3%  of  individuals  affected.  The  majority  of  individuals  with  Miller  Fisher  syndrome  have  a  unique  antibody  that  characterizes  the  disorder.